Würzburg researchers develop new therapy against skin metastases
Researchers from Würzburg are working on an innovative therapy against skin metastases after breast cancer, which often do not respond to conventional treatments. With 1.5 million euros in funding from the Federal Ministry of Education and Research, they are developing antibody-loaded silica gel fleeces that specifically activate the immune system against cancer cells. Skin metastases often occur years after breast cancer treatment when cancer cells survive in the body and spread to the skin. Although they are locally limited, effective therapies are lacking. An interdisciplinary consortium from Julius Maximilian University (JMU), University Hospital Würzburg (UKW), and the Fraunhofer Institute for Silicate Research ISC is developing ultra-thin silica gel fleeces that, loaded with antibodies, stimulate the immune response to regress or eliminate metastases. The biologically compatible fleeces, which degrade in the body, are designed at Fraunhofer ISC, with structure and antibody loading being optimized. At JMU, research is being conducted on how the fleeces activate T-cells of the immune system to attack cancer cells. At UKW, a novel 3D tissue model is being tested...

